TOP STORIES

• BUSINESS Generics Aimed for Early Stage Sales of 10 Billion Yen, in the Black for Establishing Base: Daiichi Sankyo Espha President Yoshiwaka
  April 25, 2012

• BUSINESS Astellas Senior VP Sato Shares Plans to Market Gonax Within Current Structure, MRs Dedicated to Cancer “a Future Issue”
  April 24, 2012

• BUSINESS Daiichi Sankyo Looking to Establish “Base Treatment” Position for Memary
  April 23, 2012

• ORGANIZATION JPMA Opposes Haste Adoption of Cost-Effective HTA
  April 20, 2012

• BUSINESS Takeda to Differentiate New ARB Azilva Stressing Its Strong Hypotensive Effects
  April 19, 2012

• BUSINESS JPWA, NPhA Agree to 6-Month Limit on Price Negotiations; Wholesalers’ Resolution to Be Tested for 3rd Time
  April 19, 2012

• REGULATORY Risk Management Plans to Be Required from April 2013 to Strengthen Post-Marketing Safety Measures
  April 18, 2012

• BUSINESS Eli Lilly Japan Pinning New Hopes on Solanezumab; Will the Introduction of Medicoeconomic Assessments Help?
  April 18, 2012

• BUSINESS Generic Names Used in 25% of Prescriptions Issued by GPs: Nihon Chouzai
  April 17, 2012

• BUSINESS Over 60% of Drug Makers Increased Hiring of New Graduates in 2012: Jiho Survey
  April 16, 2012

• BUSINESS Takeda to Acquire URL Pharma, Boost US Business Base Through Field of Gout
  April 13, 2012

• REGULATORY CSIMC Expert Subcommittee to Begin Discussion on Long-Listed Drugs in June, Also Deliberate on Targets for Generic Products
  April 13, 2012

• BUSINESS Pfizer Focuses on Personalized Medicine for Oncology Area with Xalkori
  April 12, 2012

• BUSINESS Sanofi Pasteur Targets Double Sales in Japan, Enters 4 Products Including IPV
  April 11, 2012

• REGULATORY PMDA to Establish Forum for Discussions Between Reviewers and Outside Researchers to Upgrade Its Ability to Review Cutting-Edge Drugs
  April 10, 2012

• BUSINESS Generics Made in India to Storm Japanese Market with Overwhelming Price Advantage
  April 10, 2012

• ACADEMIA Generic Name Prescriptions Rapidly Rise on New Premium, Tokyo Pharmaceutical Association Issues Warning
  April 9, 2012

• BUSINESS MTPC Complements Alliance with BIKEN to Establish Its Own Vaccine Development Infrastructure
  April 6, 2012

• REGULATORY MHLW to Issue 80 Requests for Development of Unapproved Drugs/Indications This Week
  April 5, 2012

• BUSINESS Mochida Aims for Sales of Over 100 Billion Yen in FY2014: New Midterm Management Plan
  April 4, 2012

ページ

• « 先頭
• ‹ Prev
• …
• 235
• 236
• 237
• 238
• 239
• 240
• 241
• 242
• 243
• …
• Next ›
• 最終 »